Newco news Asalyxa raises a seed financing to develop an ARDS therapy Feb. 23, 2021 By Lee Landenberger Asalyxa Bio Inc. has closed on an oversubscribed seed financing of more than $2 million designed to advance its lead candidate, ASX-100, into the clinic in acute respiratory distress syndrome.Read More
Diffusion completes phase Ib study of TSC in hospitalized COVID-19 patients with hypoxemia Feb. 17, 2021
NeuroRx reports preliminary phase IIb/III trial data on Zyesami in COVID-19 respiratory failure Feb. 10, 2021